Stockreport

FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction

STAAR Surgical Company  (STAA) 
Last staar surgical company earnings: 2/26 04:01 pm Check Earnings Report
PDF New FDA expansion of U.S. age indication extends EVO ICL use for patients 21 to 60 years old – making EVO ICL available to nearly 8 million additional refractive patient [Read more]